These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2166634)
21. In vitro activity of the new glycopeptide decaplanin. Neu HC; Chin NX; Niu WW Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562 [TBL] [Abstract][Full Text] [Related]
22. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus]. Duez JM; Péchinot A; Siébor E; Cordin X; Kazmierczak A Pathol Biol (Paris); 1989 Apr; 37(4):263-8. PubMed ID: 2543946 [TBL] [Abstract][Full Text] [Related]
23. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Tsuji BT; Rybak MJ Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344 [TBL] [Abstract][Full Text] [Related]
24. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Sader HS; Fritsche TR; Jones RN Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409 [TBL] [Abstract][Full Text] [Related]
25. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. LaPlante KL; Rybak MJ Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842 [TBL] [Abstract][Full Text] [Related]
26. The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species. Richter SS; Kealey DE; Murray CT; Heilmann KP; Coffman SL; Doern GV J Antimicrob Chemother; 2003 Jul; 52(1):123-7. PubMed ID: 12805265 [TBL] [Abstract][Full Text] [Related]
27. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium. el-Mady A; Mortensen JE Diagn Microbiol Infect Dis; 1991; 14(2):141-5. PubMed ID: 1651825 [TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
29. Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus. Stanley D; McGrath BJ; Lamp KC; Rybak MJ Pharmacotherapy; 1994; 14(1):35-9. PubMed ID: 8159599 [TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin). Botha PL; van Heerden CJ; Vorster E; Venter EC S Afr Med J; 1988 Jul; 74(1):16-8. PubMed ID: 2838918 [TBL] [Abstract][Full Text] [Related]
31. Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies. Stratton CW; Liu C; Ratner HB; Weeks LS Antimicrob Agents Chemother; 1987 Jul; 31(7):1014-6. PubMed ID: 2821883 [TBL] [Abstract][Full Text] [Related]
32. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Low DE; McGeer A; Poon R Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286 [TBL] [Abstract][Full Text] [Related]
33. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis. Laganas V; Alder J; Silverman JA Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541 [TBL] [Abstract][Full Text] [Related]
34. Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. Hermsen ED; Hovde LB; Hotchkiss JR; Rotschafer JC Antimicrob Agents Chemother; 2003 Dec; 47(12):3764-7. PubMed ID: 14638479 [TBL] [Abstract][Full Text] [Related]
35. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production. Marone P; Perversi L; Navarra A; Monzillo V; Sartirana E J Chemother; 1993 Jun; 5(3):151-4. PubMed ID: 8396625 [TBL] [Abstract][Full Text] [Related]
36. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL. Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469 [TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci. Machka K; Braveny I Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613 [TBL] [Abstract][Full Text] [Related]
38. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Fuchs PC; Barry AL; Brown SD Diagn Microbiol Infect Dis; 2000 Sep; 38(1):51-8. PubMed ID: 11025184 [TBL] [Abstract][Full Text] [Related]
39. Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium. Lamp KC; Rybak MJ Antimicrob Agents Chemother; 1993 Mar; 37(3):605-9. PubMed ID: 8384822 [TBL] [Abstract][Full Text] [Related]
40. In vitro bactericidal activity of daptomycin against staphylococci. Fuchs PC; Barry AL; Brown SD J Antimicrob Chemother; 2002 Mar; 49(3):467-70. PubMed ID: 11864946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]